Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Flight Attendant Uniforms Sickening Flight Attendants, Pilots

American Airlines Flight Attendants and Pilots Complain of Uniform-Related Illnesses

American Airlines flight attendants and pilots are alleging that their uniforms are sickening them due to chemicals in the uniforms.

One American Airlines flight attendant told The New York Post that her uniform may look “sexy” but it is making her sick. She is an American Airline crewmember who has been blogging about the effects the American Airlines-issued uniform policy has had on her health in recent months. The flight attendant has hypothyroidism and alleges that her flight attendant outfit has had adverse effects on her condition, causing health reactions from what she described as “chemicals” in the uniform. “I get sick every time I go to work,” she wrote. “Every time I go to work I feel terrible.” Continue reading

Posted in Defective Products |

Propecia-Related Sexual Dysfunction Linked to Depression

The active ingredient in Propecia is finasteride, known to effectively block the hormone responsible for male pattern baldness, a common genetic form of hair loss. However, a number of studies suggest it may also have damaging effects on a man’s sexual health, including decreased sex drive and erectile problems, according to drugwatch.

Propecia was approved by the U.S. Food and Drug Administration (FDA) in 1997. Before the FDA approval, manufacturer Merck & Co. released clinical trial data concerning the drug’s safety. One study showed that almost four percent of men treated with Propecia reported one or more adverse sexual side effects, compared with about two percent of men given a placebo. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Child Drownings Trigger Pool Safety Campaign

A pool safety campaign has been launched jointly by the U.S. Consumer Product Safety Commission (CPSC) and the Michael Phelps Foundation. Over 75 percent of the drownings and pool-related injuries from 2012 to 2016 involved children under the age of five, according to a recent report from the CPSC.

Since it was formed over seven years ago, the Pool Safely campaign has gathered more than 1,000 partners that aid in public outreach and education to assist parents and families to learn vital safety measures in and around pools and spas. Some of the significant partners involved in the campaign include the National Drowning Prevention Alliance, the U.S. YMCA, the Boys & Girls Clubs of America, the Red Cross, the Boy Scouts of America, and Walmart. The focus of this nationwide initiative is to reduce the number of fatal as well as non-fatal drownings or entrapments in swimming pools. Continue reading

Posted in Accident, Health Concerns |

FDA Warning Letters for Bodybuilding Products Containing Steroid-Like Substances

On June 20, 2017, the U.S. Food and Drug Administration (FDA) posted warning letters to Flex Fitness/Big Dan’s Fitness, AndroPharm, and Hardcore Formulations for illegally marketing products labeled as containing steroid and steroid-like substances and promoted to increase muscle mass and strength.

The products are marketed as dietary supplements but the FDA considers these products unapproved drugs that have not been reviewed for safety and effectiveness.   Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals |

FDA Investigates Hepatitis A Linked to Frozen Tuna

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), are assisting state and local officials in assessing the risk of hepatitis A virus exposure from contaminated frozen tuna from Sustainable Seafood Company, Vietnam, and Santa Cruz Seafood Inc., Philippines.

If unvaccinated consumers have consumed the recalled product within the last two weeks, they may need treatment to help prevent hepatitis A virus infection. Continue reading

Posted in Food Poisoning, Health Concerns |

Another Try for MDL for PPI Lawsuits – Kidney Damage Allegations

Proton pump inhibitors (PPIs) such as Nexium, Prilosec, and Prevacid are drugs used in the treatment of acid reflux or heartburn. Plaintiffs have filed lawsuits alleging that these medications caused kidney injuries and have filed a motion to consolidate 172 pending federal lawsuits to a multidistrict litigation (MDL). An MDL is frequently created to streamline a procedure by combining cases with similar complaints to be tried in one court before one judge. This lowers court costs, allows for a faster outcome, and is typically more efficient.

In each of the lawsuits against the drug manufacturers including AstraZeneca, Pfizer, Wyeth, among others, the plaintiffs allege that the drug companies failed to sufficiently warn that ingestion of prescription and over-the-counter (OTC) PPIs could cause “irreparable harm” to the kidneys, according to court documents. Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals |

More Than 400 Cases in Viagra-Melanoma Multidistrict Litigation

As of May 15, 2017, 428 men are plaintiffs in a Viagra (sildenafil) multidistrict product liability litigation in U.S. District Court for the Northern District of California.

The suit alleges that the “little blue pill,” manufactured by Pfizer, is connected to a significant increase in the risk of melanoma, the most dangerous form of skin cancer. Viagra has been prescribed to millions of men to solve problems with erectile dysfunction. Continue reading

Posted in Health Concerns, Pharmaceuticals, Viagra |

Johnson & Johnson Loses Fourth Transvaginal Mesh Trial

On May 26, 2017, health care giant Johnson & Johnson lost its fourth surgical mesh lawsuit when a Philadelphia jury returned a verdict of $2.16 million against Johnson & Johnson and its Ethicon Women’s Health and Urology division.

Observers see this fourth loss in four trials as a trend in lawsuits over alleged surgical mesh complications. Continue reading

Posted in Defective Medical Devices, Transvaginal mesh |

MusclMasster Recalls Al-ER-G Capsules due to Ephedra

MusclMasster, LLC, is recalling all bottles of Al-Er-G Capsules due to the presence of Ephedra Herb, an ingredient that has been banned by the U.S. Food and Drug Administration (FDA). Dietary supplements that contain ephedrine alkaloids pose a risk of serious health consequences, including heart attack, stroke, and death. These risks are proportionately unreasonable in light of any benefits that may result from their use.

This product was distributed from Wheat Ridge, Colorado, through a wellness center and retail store and does not contain UPC codes or expiration dates. The lot number is 314. The product was shipped to Wyoming, South Carolina, and Washington between 2016 and 2017. Continue reading

Posted in Health Concerns, Product Recalls, Recalled Food Products |

Multicounty Litigation Created for Stryker LFIT V40 Hip Lawsuits

Stryker LFIT V40 Hip Implant Lawsuits Consolidated into Multicounty Litigation

The New Jersey Supreme Court has decided to consolidate state lawsuits over the Stryker LFIT V40 hip implants into a multicounty litigation. Plaintiffs allege injuries from the LFIT Anatomic Cobalt Chromium V40 femoral heads, and allege that device makers failed to warn of the risks. Howmedica Osteonics Corp. has been named as defendant. The product in question is a metal-on-metal hip implant, a category of devices that has become controversial in recent years.

Parker Waichman LLP personal injury attorneys note that metal-on-metal hip implants have come under scrutiny following recalls and thousands of lawsuits. The firm represents numerous clients in metal-on-metal hip implant lawsuits and continues to offer free legal consultations to individuals who have questions about pursuing a case. Continue reading

Posted in Legal News |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.